Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Hepatology (Baltimore, Md.)|May 8, 2019
Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary AtresiaYongtao Xiao, Runping Liu, Xiaojiaoyang Li, et al.
Medcomm|May 6, 2026
Liver Fibrosis: Molecular Pathogenesis and Therapeutic InterventionsJiaorong Qu, Wenqing Qin, Minghang Dong, et al.
Food & Function|April 26, 2021
Tannins in <i>Terminalia bellirica</i> inhibit hepatocellular carcinoma growth by regulating EGFR-signaling and tumor immunityZihao Chang, Ping Jian, Qiunan Zhang, et al.
Advanced Healthcare Materials|January 18, 2023
A Novel Tri-Functional Liposome Re-Educates "Cold Tumor" and Abrogates Tumor Growth by Synergizing Autophagy Inhibition and PD-L1 BlockadeFei Zhou, Xiaojiaoyang Li, Xiaoyong Xue, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 25, 2026
Saikosaponins aggravate mitochondrial damage and senescence of cholangiocyte in cholestatic liver diseases by inhibiting protective autophagyGuifang Fan, Xiao Chen, Yufei Li, et al.
Acta Pharmaceutica Sinica. B|June 9, 2025
Acteoside ameliorates hepatocyte ferroptosis and hepatic ischemia-reperfusion injury <i>via</i> targeting PCBP2Kexin Jia, Yinhao Zhang, Fanghong Li, et al.
Theranostics|August 8, 2024
Intestinal epithelial damage-derived mtDNA activates STING-IL12 axis in dendritic cells to promote colitisYajie Cai, Shuo Li, Yang Yang, et al.
Journal of Ethnopharmacology|August 21, 2024
Radix Rehmanniae Praeparata extracts ameliorate hepatic ischemia-reperfusion injury by restoring lipid metabolism in hepatocytesRanyi Luo, Yinhao Zhang, Hong Wang, et al.
Antioxidants (Basel, Switzerland)|March 28, 2024
Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon ResponsesShuni Duan, Xin Li, Junsong Han, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 12, 2022
Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathwayYiqing Gu, Shuni Duan, Mingning Ding, et al.
Pageof 11